Cargando…
Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression
INTRODUCTION: Circular RNAs (circRNAs) are deregulated in many types of human cancers, including non-small cell lung cancer (NSCLC). In this study, we aimed to explore the functional role of circMYLK in NSCLC. MATERIALS AND METHODS: The expression levels of circMYLK and miR-195-5p in NSCLC tissues a...
Autores principales: | Xiong, Shuanglong, Li, Dairong, Wang, Donglin, Huang, Lumi, Liang, Guanzhong, Wu, Zhijuan, Long, Jianlin, Yang, Dan, Teng, Yan, Lei, Shuangyi, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353999/ https://www.ncbi.nlm.nih.gov/pubmed/32753964 http://dx.doi.org/10.2147/CMAR.S257386 |
Ejemplares similares
-
Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI treatment: a single-arm study
por: Long, Jianlin, et al.
Publicado: (2022) -
Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p
por: Li, Zhiqin, et al.
Publicado: (2019) -
Circular RNA MYLK serves as an oncogene to promote cancer progression via microRNA-195/cyclin D1 axis in laryngeal squamous cell carcinoma
por: Duan, Xiaohui, et al.
Publicado: (2019) -
Heterozygous Mylk3 Knockout Mice Partially Recapitulate Human DCM With Heterozygous MYLK3 Mutations
por: Tougas, Carson L., et al.
Publicado: (2019) -
Circular RNA MYLK as a prognostic biomarker in patients with cancers: A systematic review and meta‐analysis
por: Foroumadi, Roham, et al.
Publicado: (2022)